Roche soars in Q3, carried by Covid-19 test demand
Swiss pharmaceutical giant Roche has ended the year's third quarter looking better than anticipated by analysts, reports Bloomberg News, which has collected a consensus estimate.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app